LexDanaLexDanabeta
Inventor

Sumiti JAIN

Inventor
US

Overview

2→
Patents
2022–2026
Patent span
Chemistry
Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides33%
C12NMicroorganisms or enzymes33%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
PatentTitleYear
12,516,098Chimeric antigen receptor mediated cell targeting202611,512,287Targeted disruption of T cell and/or HLA receptors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to SANGAMO THERAPEUTICS INC (2)· patent assignee history
2022–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANGAMO THERAPEUTICS INC22022–2026
Locations
LocationPatentsSpan
US22022–2026